Similarities between Breast cancer and Lasofoxifene
Breast cancer and Lasofoxifene have 6 things in common (in Unionpedia): Aromatase inhibitor, Estrogen receptor, Metastatic breast cancer, Raloxifene, Selective estrogen receptor modulator, Tamoxifen.
Aromatase inhibitor
Aromatase inhibitors (AIs) are a class of drugs used in the treatment of breast cancer in postmenopausal women and gynecomastia in men.
Aromatase inhibitor and Breast cancer · Aromatase inhibitor and Lasofoxifene ·
Estrogen receptor
Estrogen receptors (ERs) are a group of proteins found inside cells.
Breast cancer and Estrogen receptor · Estrogen receptor and Lasofoxifene ·
Metastatic breast cancer
Metastatic breast cancer, also referred to as metastases, advanced breast cancer, secondary tumours, secondaries or stage 4 breast cancer, is a stage of breast cancer where the disease has spread to distant sites beyond the axillary lymph nodes.
Breast cancer and Metastatic breast cancer · Lasofoxifene and Metastatic breast cancer ·
Raloxifene
Raloxifene, developed by Eli Lilly in 1997 and sold under the brand name Evista among others, is a medication which is used in the prevention and treatment of osteoporosis in postmenopausal women and to reduce the risk of breast cancer in postmenopausal women with osteoporosis or at high risk for breast cancer.
Breast cancer and Raloxifene · Lasofoxifene and Raloxifene ·
Selective estrogen receptor modulator
Selective estrogen receptor modulators (SERMs) are a class of drugs that act on the estrogen receptor (ER).
Breast cancer and Selective estrogen receptor modulator · Lasofoxifene and Selective estrogen receptor modulator ·
Tamoxifen
Tamoxifen (TMX), sold under the brand name Nolvadex among others, is a medication that is used to prevent breast cancer in women and treat breast cancer in women and men.
The list above answers the following questions
- What Breast cancer and Lasofoxifene have in common
- What are the similarities between Breast cancer and Lasofoxifene
Breast cancer and Lasofoxifene Comparison
Breast cancer has 264 relations, while Lasofoxifene has 33. As they have in common 6, the Jaccard index is 2.02% = 6 / (264 + 33).
References
This article shows the relationship between Breast cancer and Lasofoxifene. To access each article from which the information was extracted, please visit: